• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合治疗的肺动脉高压患者运动反应情况

Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy.

作者信息

Nishizaki Mari, Ogawa Aiko, Matsubara Hiromi

机构信息

Dept of Rehabilitation, National Hospital Organization Okayama Medical Center, Okayama, Japan.

Dept of Clinical Science, National Hospital Organization Okayama Medical Center, Okayama, Japan.

出版信息

ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00725-2020. eCollection 2021 Jan.

DOI:10.1183/23120541.00725-2020
PMID:33532477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836646/
Abstract

Pulmonary arterial hypertension (PAH)-specific combination therapy improves pulmonary haemodynamics at rest in patients with PAH; nevertheless, exertional dyspnoea remains. We investigated pulmonary haemodynamic response to exercise, and the relationship to ventilatory efficiency and hypoxaemia in patients with PAH treated with combination therapy. 32 clinically stable patients with PAH undergoing combination therapy underwent cardiopulmonary exercise testing with right heart catheterisation. Haemodynamic impairment was moderate to severe before treatment. However, after treatment it was significantly improved, and the mean pulmonary arterial pressure (mPAP) at rest was <25 mmHg in 13 patients. The mPAP increased significantly from 27.9±10.7 to 45.9±16.7 mmHg (p<0.01) during exercise. The cardiac index increased inadequately, and the total pulmonary resistance (TPR) increased significantly from 5.74±3.42 to 6.58±3.82 Wood units (p<0.01). The mPAP/cardiac output (CO) slope was steep (10.0±6.7 mmHg·min·L). It significantly correlated with both the minute ventilation/carbon dioxide output slope (r=0.51, p<0.01) and peripheral arterial oxygen saturation/workload slope (r=-0.41, p=0.02). In addition, the mPAP/CO slope correlated significantly with mPAP at rest (r=0.73, p<0.01) and TPR at rest (r=0.64, p<0.01). Even after pulmonary haemodynamics at rest was significantly improved in PAH patients with PAH-specific combination therapy, the mPAP/CO slope was steep and the steep mPAP/CO slope related to decreased ventilatory efficiency and the severity of hypoxaemia. The mPAP/CO slope was steeper in patients with higher mPAP and TPR at rest.

摘要

肺动脉高压(PAH)特异性联合治疗可改善PAH患者静息时的肺血流动力学;然而,运动性呼吸困难仍然存在。我们研究了联合治疗的PAH患者运动时的肺血流动力学反应,以及与通气效率和低氧血症的关系。32例接受联合治疗的临床稳定的PAH患者接受了心肺运动试验及右心导管检查。治疗前血流动力学损害为中度至重度。然而,治疗后明显改善,13例患者静息时平均肺动脉压(mPAP)<25 mmHg。运动期间,mPAP从27.9±10.7显著增加至45.9±16.7 mmHg(p<0.01)。心脏指数增加不足,总肺阻力(TPR)从5.74±3.42显著增加至6.58±3.82伍德单位(p<0.01)。mPAP/心输出量(CO)斜率较陡(10.0±6.7 mmHg·min·L)。它与分钟通气量/二氧化碳排出量斜率(r=0.51,p<0.01)和外周动脉血氧饱和度/工作量斜率(r=-0.41,p=0.02)均显著相关。此外,mPAP/CO斜率与静息时mPAP(r=0.73,p<0.01)和静息时TPR(r=0.64,p<0.01)显著相关。即使PAH患者通过PAH特异性联合治疗使静息时肺血流动力学得到显著改善,mPAP/CO斜率仍较陡,且mPAP/CO斜率较陡与通气效率降低和低氧血症严重程度相关。静息时mPAP和TPR较高的患者mPAP/CO斜率更陡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/1451981a6dfe/00725-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/0fca78e44a84/00725-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/5f23ea0ea695/00725-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/824e277a4025/00725-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/1451981a6dfe/00725-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/0fca78e44a84/00725-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/5f23ea0ea695/00725-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/824e277a4025/00725-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7441/7836646/1451981a6dfe/00725-2020.04.jpg

相似文献

1
Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy.联合治疗的肺动脉高压患者运动反应情况
ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00725-2020. eCollection 2021 Jan.
2
Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty.肺动脉血管成形术后慢性血栓栓塞性肺动脉高压患者的运动不耐受情况
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01982-2019. Print 2020 Jul.
3
Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease.对慢性血栓栓塞性疾病患者在肺动脉内膜剥脱术前和术后进行右心导管检查。
Eur Respir J. 2018 Sep 17;52(3). doi: 10.1183/13993003.00458-2018. Print 2018 Sep.
4
Exercise pulmonary hypertension by the mPAP/CO slope in primary mitral regurgitation.通过原发性二尖瓣反流的 mPAP/CO 斜率来检测运动性肺动脉高压。
Eur Heart J Cardiovasc Imaging. 2024 Mar 27;25(4):530-538. doi: 10.1093/ehjci/jead313.
5
Strong linear relationship between heart rate and mean pulmonary artery pressure in exercising patients with severe precapillary pulmonary hypertension.在患有严重毛细血管前肺动脉高压的运动患者中,心率与平均肺动脉压之间存在强烈的线性关系。
Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H769-77. doi: 10.1152/ajpheart.00258.2013. Epub 2013 Jun 21.
6
Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.肺动脉高压患者的运动能力和通气效率。
J Am Heart Assoc. 2023 Jun 6;12(11):e026890. doi: 10.1161/JAHA.122.026890. Epub 2023 Jun 1.
7
Pulmonary vascular response patterns during exercise in interstitial lung disease.特发性肺纤维化患者运动时的肺血管反应模式。
Eur Respir J. 2015 Sep;46(3):738-49. doi: 10.1183/09031936.00191014. Epub 2015 May 14.
8
Criteria for diagnosis of exercise pulmonary hypertension.运动性肺动脉高压的诊断标准。
Eur Respir J. 2015 Sep;46(3):728-37. doi: 10.1183/09031936.00021915. Epub 2015 May 28.
9
Effects of body position on exercise capacity and pulmonary vascular pressure-flow relationships.体位对运动能力及肺血管压力-血流关系的影响。
J Appl Physiol (1985). 2016 Nov 1;121(5):1145-1150. doi: 10.1152/japplphysiol.00372.2016. Epub 2016 Oct 7.
10
Definition, classification and diagnosis of pulmonary hypertension.肺动脉高压的定义、分类和诊断。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01324-2024. Print 2024 Oct.

引用本文的文献

1
High Right Ventricular Afterload during Exercise in Patients with Pulmonary Arterial Hypertension.肺动脉高压患者运动时右心室后负荷升高
J Clin Med. 2021 May 9;10(9):2024. doi: 10.3390/jcm10092024.

本文引用的文献

1
Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension.日本特发性/遗传性肺动脉高压患者的生存情况
Am J Cardiol. 2017 May 1;119(9):1479-1484. doi: 10.1016/j.amjcard.2017.01.015. Epub 2017 Feb 9.
2
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.马昔腾坦治疗肺动脉高压的安全性、有效性及临床应用价值
Drug Des Devel Ther. 2016 May 18;10:1675-82. doi: 10.2147/DDDT.S88612. eCollection 2016.
3
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
4
Criteria for diagnosis of exercise pulmonary hypertension.运动性肺动脉高压的诊断标准。
Eur Respir J. 2015 Sep;46(3):728-37. doi: 10.1183/09031936.00021915. Epub 2015 May 28.
5
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
6
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases.心肺疾病中运动对肺血管血液动力学的反应。
Circulation. 2013 Sep 24;128(13):1470-9. doi: 10.1161/CIRCULATIONAHA.112.000667.
7
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses.肺动脉高压:从濒死边缘到多项临床试验的荟萃分析
Eur Heart J. 2010 Sep;31(17):2080-6. doi: 10.1093/eurheartj/ehq152. Epub 2010 May 26.
8
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.吸入性曲前列尼尔联合口服药物治疗肺动脉高压的随机对照临床试验。
J Am Coll Cardiol. 2010 May 4;55(18):1915-22. doi: 10.1016/j.jacc.2010.01.027.
9
Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.心力衰竭中通气效率的决定因素:右心室功能和肺血管张力的作用。
Circ Heart Fail. 2008 Nov;1(4):227-33. doi: 10.1161/CIRCHEARTFAILURE.108.785501.
10
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.健康受试者静息和运动时的肺动脉压:一项系统评价。
Eur Respir J. 2009 Oct;34(4):888-94. doi: 10.1183/09031936.00145608. Epub 2009 Mar 26.